TLSI — TRISALUS LIFE SCIENCES INC. (Healthcare >> Medical Devices)
TLSI FAQ
What is TLSI's P/E ratio?
TRISALUS LIFE SCIENCES INC. (TLSI) currently trades at a P/E ratio of 131.69.
What is TLSI's ROE?
TRISALUS LIFE SCIENCES INC. reports a Return on Equity (ROE) of -213.27%.
What is TLSI's dividend yield?
TRISALUS LIFE SCIENCES INC. offers a dividend yield of 0.00%.
What is TLSI's Deepscope Quality Score?
Deepscope rates TLSI's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TLSI?
Deepscope's AI Timing Score for TLSI is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TLSI belong to?
TRISALUS LIFE SCIENCES INC. is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 3.17
Price
-0.13
(-3.94%)
Day Change
|
|
|---|
TLSI Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.17 |
| PBV / Sector |
15.83 / 7.50
|
| Earning Per Share | -0.43 |
| PE / Sector |
131.69 / 29.01
|
| PEG or PE/Growth / Sector |
-18.98 / 0.39
|
| Average 1M Daily Value |
2.29 M
GREAT
|
| Average 1W Daily Value |
0.84 M
GREAT
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
41% |
| Khả năng kiếm lợi nhuận |
|
56% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:08:44 |
| Symbol | TLSI |
| Name | TRISALUS LIFE SCIENCES INC. |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 61.42 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 202.67 / 18,389.26 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 6272 West 91st Avenue, Westminster, CO, United States, 80031
Phone: 888 321 5212
Website: https://trisaluslifesci.com
Employees: 102
Sector: Healthcare >> Medical Devices
Description: TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google